2020 Q2 Form 10-Q Financial Statement

#000155837020009288 Filed on August 05, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2019 Q4 2019 Q2
Revenue $6.934M $10.85M $11.48M
YoY Change -39.59% 108400.0% 201.29%
Cost Of Revenue $6.517M $6.450M $11.16M
YoY Change -41.62% 12800.0% 400.58%
Gross Profit $417.0K $4.400M $316.0K
YoY Change 31.96% -11100.0% -80.0%
Gross Profit Margin 6.01% 40.55% 2.75%
Selling, General & Admin $1.190M $1.230M $1.150M
YoY Change 3.48% 2.5% 4.55%
% of Gross Profit 285.37% 27.95% 363.92%
Research & Development $343.0K $970.0K $292.0K
YoY Change 17.47% 32.88% -72.19%
% of Gross Profit 82.25% 22.05% 92.41%
Depreciation & Amortization $1.050M $1.100M $1.100M
YoY Change -4.55% 22.22% 22.22%
% of Gross Profit 251.8% 25.0% 348.1%
Operating Expenses $2.227M $2.340M $292.0K
YoY Change 662.67% 13.59% -87.14%
Operating Profit -$1.810M $2.060M -$1.763M
YoY Change 2.67% -198.1% 155.51%
Interest Expense $195.0K $30.00K -$280.0K
YoY Change -169.64% -92.5% 7.69%
% of Operating Profit 1.46%
Other Income/Expense, Net $17.00K $30.00K $15.00K
YoY Change 13.33% -25.0% -99.58%
Pretax Income -$2.230M $2.120M -$2.030M
YoY Change 9.85% -226.95% -178.38%
Income Tax
% Of Pretax Income
Net Earnings -$2.227M $2.120M -$2.031M
YoY Change 9.65% -226.95% -178.42%
Net Earnings / Revenue -32.12% 19.54% -17.69%
Basic Earnings Per Share -$0.02
Diluted Earnings Per Share -$13.90K $13.24K -$12.70K
COMMON SHARES
Basic Shares Outstanding 159.8M
Diluted Shares Outstanding 160.5M shares

Balance Sheet

Concept 2020 Q2 2019 Q4 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.600M $7.800M $6.500M
YoY Change -13.85% 21.88% -13.33%
Cash & Equivalents $5.567M $7.403M $6.536M
Short-Term Investments $1.800M $1.600M
Other Short-Term Assets $1.000M $900.0K $1.100M
YoY Change -9.09% 12.5% 37.5%
Inventory $7.485M $7.426M $7.100M
Prepaid Expenses $969.0K $885.0K
Receivables $0.00 $0.00 $0.00
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $14.03M $8.310M $14.70M
YoY Change -4.57% -8.68% 77.11%
LONG-TERM ASSETS
Property, Plant & Equipment $22.81M $23.63M $68.90M
YoY Change -66.89% -66.72% -1.43%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $7.500M $14.90M $9.500M
YoY Change -21.05% 15.5% -3.06%
Total Long-Term Assets $72.23M $82.08M $78.40M
YoY Change -7.87% -10.1% -10.19%
TOTAL ASSETS
Total Short-Term Assets $14.03M $8.310M $14.70M
Total Long-Term Assets $72.23M $82.08M $78.40M
Total Assets $86.26M $90.39M $93.10M
YoY Change -7.35% -9.97% -2.62%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $598.0K $523.0K $600.0K
YoY Change -0.33% -12.83% 0.0%
Accrued Expenses $1.700M $1.800M $1.900M
YoY Change -10.53% 0.0% -9.52%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.683M $0.00 $5.200M
YoY Change -67.63% -100.0% 6.12%
Total Short-Term Liabilities $4.013M $2.283M $7.700M
YoY Change -47.88% -69.56% 1.32%
LONG-TERM LIABILITIES
Long-Term Debt $11.46M $0.00 $7.000M
YoY Change 63.71% -100.0% -42.62%
Other Long-Term Liabilities $498.0K $575.0K $32.40M
YoY Change -98.46% -98.17% 18.68%
Total Long-Term Liabilities $43.29M $43.77M $39.40M
YoY Change 9.87% 6.77% -0.25%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.013M $2.283M $7.700M
Total Long-Term Liabilities $43.29M $43.77M $39.40M
Total Liabilities $47.30M $46.06M $47.10M
YoY Change 0.43% -5.04% 0.0%
SHAREHOLDERS EQUITY
Retained Earnings -$171.3M -$165.4M
YoY Change
Common Stock $206.5M $206.1M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $38.96M $44.33M $45.99M
YoY Change
Total Liabilities & Shareholders Equity $86.26M $90.39M $93.10M
YoY Change -7.35% -9.97% -2.62%

Cashflow Statement

Concept 2020 Q2 2019 Q4 2019 Q2
OPERATING ACTIVITIES
Net Income -$2.227M $2.120M -$2.031M
YoY Change 9.65% -226.95% -178.42%
Depreciation, Depletion And Amortization $1.050M $1.100M $1.100M
YoY Change -4.55% 22.22% 22.22%
Cash From Operating Activities -$930.0K $4.440M $3.860M
YoY Change -124.09% -219.35% -196.02%
INVESTING ACTIVITIES
Capital Expenditures -$10.00K -$100.0K -$110.0K
YoY Change -90.91% 900.0%
Acquisitions
YoY Change
Other Investing Activities $20.00K $20.00K $0.00
YoY Change 0.0% -100.0%
Cash From Investing Activities $0.00 -$80.00K -$110.0K
YoY Change -100.0% -900.0% -103.11%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $4.680M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 890.0K 30.00K -1.150M
YoY Change -177.39% -102.08% 0.0%
NET CHANGE
Cash From Operating Activities -930.0K 4.440M 3.860M
Cash From Investing Activities 0.000 -80.00K -110.0K
Cash From Financing Activities 890.0K 30.00K -1.150M
Net Change In Cash -40.00K 4.390M 2.600M
YoY Change -101.54% -185.24% -259.51%
FREE CASH FLOW
Cash From Operating Activities -$930.0K $4.440M $3.860M
Capital Expenditures -$10.00K -$100.0K -$110.0K
Free Cash Flow -$920.0K $4.540M $3.970M
YoY Change -123.17% -222.37% -198.76%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
00-0000000
CY2020Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2019Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
160478059
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0001375205
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
160478059
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-33905
dei Entity Registrant Name
EntityRegistrantName
UR-ENERGY INC
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
Z4
dei Entity Address Address Line1
EntityAddressAddressLine1
10758 West Centennial Road, Suite 200
dei Entity Address City Or Town
EntityAddressCityOrTown
Littleton
dei Entity Address State Or Province
EntityAddressStateOrProvince
CO
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
80127
dei City Area Code
CityAreaCode
720
dei Local Phone Number
LocalPhoneNumber
981-4588
dei Security12b Title
Security12bTitle
Common stock
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2020Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
160478059
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5567000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7752000
CY2020Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
7000
CY2019Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
22000
CY2020Q2 urg Inventory Current
InventoryCurrent
7485000
CY2020Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
969000
CY2019Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
885000
CY2020Q2 us-gaap Assets Current
AssetsCurrent
14028000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
8659000
CY2019Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
7426000
CY2020Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
7463000
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
7463000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
23630000
CY2020Q2 us-gaap Mineral Properties Net
MineralPropertiesNet
41958000
CY2019Q4 us-gaap Mineral Properties Net
MineralPropertiesNet
43212000
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22812000
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
575000
CY2019Q4 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
30972000
CY2020Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
498000
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
12215000
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
70000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
12000
CY2020Q2 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
31260000
CY2020Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
72233000
CY2019Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
81731000
CY2020Q2 us-gaap Assets
Assets
86261000
CY2019Q4 us-gaap Assets
Assets
90390000
CY2020Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2255000
CY2019Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2211000
CY2020Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
1683000
CY2020Q2 us-gaap Accrued Reclamation Costs Current
AccruedReclamationCostsCurrent
75000
CY2019Q4 us-gaap Accrued Reclamation Costs Current
AccruedReclamationCostsCurrent
72000
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
4013000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2283000
CY2020Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
11460000
CY2020Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
43288000
CY2019Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
43774000
CY2020Q2 us-gaap Liabilities
Liabilities
47301000
CY2019Q4 us-gaap Liabilities
Liabilities
46057000
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
160478059
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
160478059
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
185754000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
185754000
CY2020Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
20781000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
20317000
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
3685000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
3654000
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-171260000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-165392000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
38960000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
44333000
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
86261000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
90390000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6934000
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11479000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8304000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16291000
CY2020Q2 us-gaap Cost Of Revenue
CostOfRevenue
6517000
CY2019Q2 us-gaap Cost Of Revenue
CostOfRevenue
11163000
us-gaap Cost Of Revenue
CostOfRevenue
9622000
us-gaap Cost Of Revenue
CostOfRevenue
16309000
CY2020Q2 us-gaap Gross Profit
GrossProfit
417000
CY2019Q2 us-gaap Gross Profit
GrossProfit
316000
us-gaap Gross Profit
GrossProfit
-1318000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2440000
us-gaap Gross Profit
GrossProfit
-18000
CY2020Q2 urg Exploration And Evaluation
ExplorationAndEvaluation
554000
CY2019Q2 urg Exploration And Evaluation
ExplorationAndEvaluation
490000
urg Exploration And Evaluation
ExplorationAndEvaluation
945000
urg Exploration And Evaluation
ExplorationAndEvaluation
1264000
CY2020Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
343000
CY2019Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
292000
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
616000
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
458000
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1187000
CY2019Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1153000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3291000
CY2020Q2 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
143000
CY2019Q2 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
144000
us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
288000
us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
287000
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1810000
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1763000
us-gaap Operating Income Loss
OperatingIncomeLoss
-5607000
us-gaap Operating Income Loss
OperatingIncomeLoss
-5318000
CY2020Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-195000
CY2019Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-168000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-327000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-364000
CY2020Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
231000
CY2019Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
105000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-42000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
638000
CY2020Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-8000
CY2019Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-10000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
7000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-28000
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
17000
CY2019Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
15000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
17000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
15000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-2227000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-2031000
us-gaap Net Income Loss
NetIncomeLoss
-5868000
us-gaap Net Income Loss
NetIncomeLoss
-6333000
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
160478059
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
159820583
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
160478059
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
159775245
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-2227000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-2031000
us-gaap Net Income Loss
NetIncomeLoss
-5868000
us-gaap Net Income Loss
NetIncomeLoss
-6333000
CY2020Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
4000
CY2019Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-24000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
31000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-23000
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2223000
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2055000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5837000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6356000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
51847000
CY2019Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
134000
CY2019Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-6000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
188000
CY2019Q1 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
-4301000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
47728000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13030000
CY2019Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-1000
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
182000
CY2019Q2 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
-2055000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
45988000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
44333000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
234000
CY2020Q1 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
-3614000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
40953000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
230000
CY2020Q2 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
-2223000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
38960000
us-gaap Net Income Loss
NetIncomeLoss
-5868000
us-gaap Net Income Loss
NetIncomeLoss
-6333000
us-gaap Share Based Compensation
ShareBasedCompensation
464000
us-gaap Share Based Compensation
ShareBasedCompensation
370000
us-gaap Other Noncash Expense
OtherNoncashExpense
4456000
us-gaap Other Noncash Expense
OtherNoncashExpense
4103000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2164000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2201000
us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
288000
us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
287000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
35000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
60000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-42000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
638000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
16000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
7000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
28000
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
3000
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-2000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-14000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-4000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4515000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1462000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
67000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
174000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
36000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
76000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3055000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2664000
us-gaap Payments To Acquire Mineral Rights
PaymentsToAcquireMineralRights
8000
urg Other Deposits Increase Decrease
OtherDepositsIncreaseDecrease
5000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
18000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
34000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
125000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-21000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-133000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
134000
urg Restricted Stock Unit Redeemed For Cash
RestrictedStockUnitRedeemedForCash
7000
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
893000
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13997000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
167000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15215000
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
2555000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
893000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2428000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-2000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
64000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2185000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13830000
dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2004-03-22
CY2020Q2 urg Accounts Payable Trade Accounts Accrued Trade And Payroll Liabilities
AccountsPayableTradeAccountsAccruedTradeAndPayrollLiabilities
700000
CY2020Q2 us-gaap Notes Payable
NotesPayable
13300000
CY2020Q2 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
12400000
urg Principal Payment Deferment Term
PrincipalPaymentDefermentTerm
P18M
CY2020Q2 urg Number Of Payments Due In Twelve Months
NumberOfPaymentsDueInTwelveMonths
2
CY2020Q2 urg Small Business Administration Payroll Protection Program
SmallBusinessAdministrationPayrollProtectionProgram
900000
us-gaap Nature Of Operations
NatureOfOperations
<table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin-bottom:0pt;margin-top:0pt;"><b style="font-size:11pt;font-weight:bold;">1.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin-bottom:0pt;margin-top:0pt;"><b style="font-size:11pt;font-weight:bold;">Nature of Operations</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt 0pt 0pt 18pt;"><span style="font-size:11pt;margin-left:0pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt 0pt 0pt 18pt;"><span style="font-size:11pt;">Ur-Energy Inc. (the “Company”) was incorporated on </span><span style="font-size:11pt;">March 22, 2004</span><span style="font-size:11pt;"> under the laws of the Province of Ontario. The Company was continued under the Canada Business Corporations Act on August 8, 2006. Headquartered in Littleton, Colorado, the Company is an exploration stage mining company, as defined by U.S. Securities and Exchange Commission (“SEC”) Industry Guide 7. The Company is engaged in uranium mining and recovery operations, with activities including the acquisition, exploration, development and production of uranium mineral resources located in Wyoming. In August 2013, the Company commenced uranium production at its Lost Creek Project in Wyoming.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;margin:0pt 0pt 0pt 18pt;">Due to the nature of the uranium mining methods used by the Company on the Lost Creek Property, and the definition of “mineral reserves” under National Instrument 43-101 (“NI 43-101”), which uses the Canadian Institute of Mining, Metallurgy and Petroleum (“CIM”) Definition Standards, the Company has not determined whether the property contains mineral reserves. However, the Company’s “<i style="font-style:italic;">Amended</i> <i style="font-style:italic;">Preliminary Economic Assessment of the Lost Creek Property, Sweetwater County, Wyoming,</i>” February 8, 2016 (“Lost Creek PEA”), outlines the potential viability of the Lost Creek Property. The recoverability of amounts recorded for mineral properties is dependent upon the discovery of economic resources, the ability of the Company to obtain the necessary financing to develop the properties and upon attaining future profitable production from the properties or sufficient proceeds from disposition of the properties.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt 0pt 0pt 27pt;"><span style="margin-left:0pt;visibility:hidden;">​</span></p>
CY2019Q4 us-gaap Inventory Net
InventoryNet
7426000
CY2020Q2 urg Inventory Current
InventoryCurrent
7485000
CY2020Q2 us-gaap Cash
Cash
1518000
CY2019Q4 us-gaap Cash
Cash
1755000
CY2020Q2 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
4049000
CY2019Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
5997000
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5567000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7752000
CY2020Q2 us-gaap Inventory Net
InventoryNet
7485000
CY2019Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
7426000
us-gaap Valuation Allowances And Reserves Period Increase Decrease
ValuationAllowancesAndReservesPeriodIncreaseDecrease
4456000
CY2019 us-gaap Valuation Allowances And Reserves Period Increase Decrease
ValuationAllowancesAndReservesPeriodIncreaseDecrease
10263000
CY2019Q4 us-gaap Mineral Properties Net
MineralPropertiesNet
43212000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
1254000
CY2020Q2 us-gaap Mineral Properties Net
MineralPropertiesNet
41958000
CY2013Q4 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
6700000
CY2013Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Noncurrent Liabilities Other
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
5700000
CY2020Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
39231000
CY2020Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
16419000
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22812000
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
39188000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
15558000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
23630000
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
598000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
523000
CY2020Q2 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
1563000
CY2019Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
1483000
CY2020Q2 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
94000
CY2019Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
205000
CY2020Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2255000
CY2019Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2211000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
200000
CY2020Q2 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
17000
CY2020Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
1683000
CY2020Q2 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
174000
CY2019Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
226000
CY2020Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
11460000
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
12215000
us-gaap Debt Instrument Periodic Payment
DebtInstrumentPeriodicPayment
14617000
CY2020Q2 urg Estimated Future Cash Undiscounted Amount
EstimatedFutureCashUndiscountedAmount
29800000
CY2020Q2 urg Estimated Future Cost To Complete Reclamation Including Inflation
EstimatedFutureCostToCompleteReclamationIncludingInflation
39900000
CY2019Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
30972000
CY2018Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
30384000
CY2019 us-gaap Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
11000
us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
288000
CY2019 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
577000
CY2020Q2 us-gaap Asset Retirement Obligation
AssetRetirementObligation
31260000
CY2019Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
30972000
CY2020Q2 urg Class Of Warrants Or Right Shares Issued On Exercise
ClassOfWarrantsOrRightSharesIssuedOnExercise
6531439
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0.84
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0.59
CY2020Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.00
CY2020Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-232000
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
41000
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
11076583
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.64
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
51798
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
10824785
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.61
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
0
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
100000
CY2020Q2 us-gaap Share Price
SharePrice
0.70
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
0
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
1155928
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
0.65
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
13433
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
0.59
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
1142495
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
0.62
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
1142495
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P0Y11M8D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
583000
CY2019Q3 urg Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Vested Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedOutstandingNumber
54431
CY2019Q4 urg Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Number Redeemed For Common Shares
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsNumberRedeemedForCommonShares
28686
CY2019Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
13062878
CY2019Q4 urg Class Of Warrants Or Right Shares Issued On Exercise
ClassOfWarrantsOrRightSharesIssuedOnExercise
6531439
CY2019Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.00
CY2020Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
13062878
CY2020Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.00
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
16291000
us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
1.000
CY2020Q2 us-gaap Share Based Compensation
ShareBasedCompensation
200000
us-gaap Share Based Compensation
ShareBasedCompensation
500000
CY2019Q2 us-gaap Share Based Compensation
ShareBasedCompensation
200000
us-gaap Share Based Compensation
ShareBasedCompensation
400000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
100000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
urg Revenue From Contract With Customer Excluding Assessed Tax And Disposal Fee Income
RevenueFromContractWithCustomerExcludingAssessedTaxAndDisposalFeeIncome
8300000
urg Revenue From Contract With Customer Excluding Assessed Tax And Disposal Fee Income
RevenueFromContractWithCustomerExcludingAssessedTaxAndDisposalFeeIncome
16289000
urg Disposal Fee Income
DisposalFeeIncome
4000
urg Disposal Fee Income
DisposalFeeIncome
2000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
8304000
us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
1.000
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5567000
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6536000
CY2020Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
7463000
CY2019Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
7461000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13030000
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13997000
CY2020Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
900000
CY2020Q2 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
500000
urg Sensitivity Analysis Of Fair Value Of Interests Continued To Be Held By Transferor Servicing Assets Or Liabilities Change In Basis Points
SensitivityAnalysisOfFairValueOfInterestsContinuedToBeHeldByTransferorServicingAssetsOrLiabilitiesChangeInBasisPoints
100
CY2020Q3 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
400000

Files In Submission

Name View Source Status
0001558370-20-009288-index-headers.html Edgar Link pending
0001558370-20-009288-index.html Edgar Link pending
0001558370-20-009288.txt Edgar Link pending
0001558370-20-009288-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
urg-20200630.xsd Edgar Link pending
urg-20200630x10q.htm Edgar Link pending
urg-20200630x10q_htm.xml Edgar Link completed
urg-20200630xex31d1.htm Edgar Link pending
urg-20200630xex31d2.htm Edgar Link pending
urg-20200630xex32d1.htm Edgar Link pending
urg-20200630xex32d2.htm Edgar Link pending
urg-20200630_cal.xml Edgar Link unprocessable
urg-20200630_def.xml Edgar Link unprocessable
urg-20200630_lab.xml Edgar Link unprocessable
urg-20200630_pre.xml Edgar Link unprocessable